Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 ): Complete Statistical AnalysisIndependent statistical analysis of Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 ): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy: Complete Statistical AnalysisIndependent statistical analysis of Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03634306).
- ULYM11011Independent statistical analysis of Imexon for Relapsed Follicular and Aggressive Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01314014).
- Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with…
- Uncontrolled Hypertension Among the Homeless: Complete Statistical AnalysisIndependent statistical analysis of Uncontrolled Hypertension Among the Homeless: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05187013).
- UNCOVER-3Independent statistical analysis of A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01646177).
- Understanding Childhood Infection, Inflammation and Allergy: Complete Statistical AnalysisIndependent statistical analysis of Understanding Childhood Infection, Inflammation and Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01022268).
- Understanding Disparities in Healthcare and Primary Care Provider Quality: Complete Statistical AnalysisIndependent statistical analysis of Understanding Disparities in Healthcare and Primary Care Provider Quality: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02626910).
- Understanding Experimentally Induced Hot Flushes: Complete Statistical AnalysisIndependent statistical analysis of Understanding Experimentally Induced Hot Flushes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455689).
- Understanding Non-Response in Spine Fusion Surgery: Complete Statistical AnalysisIndependent statistical analysis of Understanding Non-Response in Spine Fusion Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02611479).
- Understanding the Sleep Apnea/Insomnia Interaction: Complete Statistical AnalysisIndependent statistical analysis of Understanding the Sleep Apnea/Insomnia Interaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01824472).
- Underutilization of Hospice in Older African Americans: Complete Statistical AnalysisIndependent statistical analysis of Underutilization of Hospice in Older African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04458090).
- Undiagnosed Hepatitis C Infection in an Urban Hospital: Complete Statistical AnalysisIndependent statistical analysis of Undiagnosed Hepatitis C Infection in an Urban Hospital: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01957085).
- UNIFIIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate…
- UNIKIndependent statistical analysis of A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- UNITE Study: Understanding New Interventions With GBM ThErapy: Complete Statistical AnalysisIndependent statistical analysis of UNITE Study: Understanding New Interventions With GBM ThErapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03419403).
- UNITE-001Independent statistical analysis of A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia: primary endpoint results, effect estimate with confidence interval,…
- Unite-CNMIndependent statistical analysis of Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- UNITSIndependent statistical analysis of The Urinary Incontinence Treatment Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03057834).
- Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- UNIVERSEIndependent statistical analysis of Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure: primary endpoint results, effect estimate…
- University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial): Complete Statistical AnalysisIndependent statistical analysis of University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Unrelated Umbilical Cord Blood (UBC)Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Unrelated Umbilical Cord Blood (UBC)Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01768845).
- UNTOUCHEDIndependent statistical analysis of Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Up-Down Determination of the ED90 of Phenylephrine for Hypotension Prophylaxis in Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of Up-Down Determination of the ED90 of Phenylephrine for Hypotension Prophylaxis in Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- UPLIFTIndependent statistical analysis of Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- UPLIFT-BoneIndependent statistical analysis of Utilizing Protein During Weight Loss to Impact Physical Function and Bone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Upper Extremity Lymphatic Mapping for Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Upper Extremity Lymphatic Mapping for Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717886).
- upreACH-2Independent statistical analysis of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- UPSTARTIndependent statistical analysis of Using Peer Support to Aid in Prevention and Treatment in Prediabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- UPTIndependent statistical analysis of Uterotonic Prophylaxis Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02408965).
- Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder: Complete Statistical AnalysisIndependent statistical analysis of Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- UPWARDIndependent statistical analysis of A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide: primary endpoint results, effect estimate with confidence interval,…
- UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort): Complete Statistical AnalysisIndependent statistical analysis of UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04075656).
- Urease Breath Test for Rapid Characterization of Pneumonia: Complete Statistical AnalysisIndependent statistical analysis of Urease Breath Test for Rapid Characterization of Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03100760).
- Uric Acid and the Endothelium in CKD: Complete Statistical AnalysisIndependent statistical analysis of Uric Acid and the Endothelium in CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01228903).
- Uridine Adolescent Bipolar Depression Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Uridine Adolescent Bipolar Depression Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01805440).
- URIDxEDIndependent statistical analysis of Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02957136).
- Urinalysis Results in Healthy Individuals: Complete Statistical AnalysisIndependent statistical analysis of Urinalysis Results in Healthy Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04055675).
- Urinary Cytokines in Patients With Overactive Bladder (OAB): Complete Statistical AnalysisIndependent statistical analysis of Urinary Cytokines in Patients With Overactive Bladder (OAB): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00868621).
- Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products: Complete Statistical AnalysisIndependent statistical analysis of Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial: Complete Statistical AnalysisIndependent statistical analysis of Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Urinary Track Infection Prevention After Urogynecological Surgery: Complete Statistical AnalysisIndependent statistical analysis of Urinary Track Infection Prevention After Urogynecological Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03818321).
- URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- urochesterIndependent statistical analysis of Feasibility of the Memory and Attention Adaptation-Training Geriatrics Intervention in Older Cancer Survivors With Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients: Complete Statistical AnalysisIndependent statistical analysis of Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02044510).